Skip to content
value.today

Intermolecular Inc.

Total raised
$15 M
1 round on record
Latest round
$15 M
Mar 2011
First round on record
Mar 2011
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Intermolecular Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2011$15 MNo. 1$10 to $50 million

Intermolecular Inc.: Raise no. 1, Mar 2011

Investors in this round

7 investors had bought by the notice of Mar 10, 2011: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Intermolecular Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $25 M offered; $10 M still to sell
Smallest investment taken
$1
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chi I. Lang · Executive Officer
  • David E. Lazovsky · Executive Officer, Director
  • Imran L. Hashim, Ph.D. · Executive Officer
  • J. Craig Hunter · Executive Officer
  • John R. Behnke · Executive Officer
  • Peter L. Eidelman · Executive Officer
  • Sandeep Craig Jaggi, Ph.D. · Executive Officer
  • Tony P. Chiang · Executive Officer
  • Yoshiki E. Ashizawa · Executive Officer
  • Bruce M. McWilliams, Ph.D. · Director
  • George M. Scalise · Director
  • Irwin L. Federman · Director
  • Isy L. Goldwasser · Director
  • John L. Walecka · Director
  • Thomas R. Baruch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick A. Pohlen, Secretary. Source: SEC Form D, newest notice filed Mar 10, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Intermolecular Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2011).

    SEC Form D · Mar 2011

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Mar 2011

That is all the official record says: Intermolecular Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

10 named in official filings. Open an investor to see everything it has backed.

Investors in Intermolecular Inc.
InvestorKindAmountRoundRoleSource
Atmi IncCompanynot statednot statedHeld Series C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
CMEA Ventures VI GmbH & Co. KGVenture capitalnot statednot statedHeld Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Cmea Ventures VI LPVenture capitalnot statednot statedHeld Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
CMEA Ventures VI Management, L.P.Venture capitalnot statednot statedHeld Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Presidio Management Group IX, L.L.C.Fund or asset managernot statednot statedHeld Series B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Redpoint Associates II, LLCOthernot statednot statedHeld Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Redpoint Ventures II, LLCVenture capitalnot statednot statedHeld Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Redpoint Ventures II, L.P.Venture capitalnot statednot statedHeld Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Symyx Technologies IncCompanynot statednot statedHeld Series C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3
U S Venture Partners IX L.P.Venture capitalnot statednot statedHeld Series B, C, D and E preferred stock, 10% owner (Form 3, 2011)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Intermolecular Inc.
NameRoleNamed in
Chi I. LangExecutive officerMar 2011
David E. LazovskyExecutive officerMar 2011
Imran L. Hashim, Ph.D.Executive officerMar 2011
J. Craig HunterExecutive officerMar 2011
John R. BehnkeExecutive officerMar 2011
Peter L. EidelmanExecutive officerMar 2011
Sandeep Craig Jaggi, Ph.D.Executive officerMar 2011
Tony P. ChiangExecutive officerMar 2011
Yoshiki E. AshizawaExecutive officerMar 2011
Bruce M. McWilliams, Ph.D.DirectorMar 2011
David E. LazovskyDirectorMar 2011
George M. ScaliseDirectorMar 2011
Irwin L. FedermanDirectorMar 2011
Isy L. GoldwasserDirectorMar 2011
John L. WaleckaDirectorMar 2011
Thomas R. BaruchDirectorMar 2011